Summary
Researchers at the University of Reading in England are exploring how mRNA technology used in COVID vaccines might help reduce muscle damage in snakebite victims. The study showed that this technology could protect muscles from damage caused by venom from the terciopelo snake found in Central and South America. This approach might lead to new treatments that lower the risk of permanent disabilities from snakebites.
Key Facts
- mRNA technology, used in COVID vaccines, might also reduce muscle damage from snakebites.
- The University of Reading tested this on venom from the terciopelo snake, common in Central and South America.
- The treatment uses mRNA to produce antibodies that protect against venom-induced muscle damage.
- In lab tests, the treatment reduced damage in human muscle cells within 12-24 hours of injection.
- In mice, the treatment provided protection against muscle injury 48 hours before venom exposure.
- Current antivenoms mainly target toxins in the bloodstream, often missing muscle tissue damage.
- Researchers aim to expand this method to target multiple venom toxins.
- Challenges include the time needed for antibody development and storage issues in remote locations.
